Researchers at the Harvard-affiliated Brigham and Women’s Hospital have developed a disease-responsive hydrogel for anti-inflammatory drug delivery. The hydrogel could be injected into joints in patients with inflammatory arthritis for long-term local treatment. The gel breaks down in response to enzymes that are increased in an inflamed joint dur (Read more...)